Joseph A Vetro

5PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyMicro- and nanosystemsMolecular targetsGlycoconjugatesParticle physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2025
Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant Staphylococcus aureus USA300.

Jason P Stewart, Caleb M Sandall, Jacob E Parriott

|Sep 23, 2022
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization.

Jacob E Parriott, Jason P Stewart, D David Smith

|Jan 25, 2022
Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC.

Zhen Ye, Mai Mohamed Abdelmoaty, Stephen M Curran

|Apr 03, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.

Abdulraman M Alshammari, D David Smith, Jake Parriott

|Mar 21, 2017
Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

Bala V K Karuturi, Shailendra B Tallapaka, Pravin Yeapuri

Pageof 1

Frequent Collaborators

2 joint publications

D David Smith

1 joint publications

Yuxiang Dong

1 joint publications

Donald R Ronning

1 joint publications

Jonathan L Vennerstrom